Trade Ideas September 25, 2026 08:15 AM

Berkshire Under New Stewardship: A Pragmatic Long Trade Backed by Capital Allocation

Greg Abel’s playbook preserves Berkshire’s DNA—buy selectively into a long-term trade anchored to conservative valuation and strong cash generation.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
BRK.A

Berkshire Hathaway remains a uniquely diversified cash machine trading at reasonable multiples for a $1.08T conglomerate. Management continuity on capital allocation plus recent opportunistic buys give investors a clear, actionable long trade: enter near $759,702, stop at $698,000, target the 52-week high at $806,102 over a long-term (180 trading days) horizon.

Berkshire Under New Stewardship: A Pragmatic Long Trade Backed by Capital Allocation
BRK.A
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Berkshire trades at ~12.6-12.8x earnings and ~1.45x book, reasonable for a diversified conglomerate.
  • Free cash flow of ~$24.2B supports buybacks, acquisitions, and capital returns under new stewardship.
  • Conservative balance sheet (debt/equity ~0.17) provides optionality in market stress.
  • Actionable trade: long at $759,702.235 with a stop at $698,000 and target at $806,102.81 over 180 trading days.

Hook + thesis

Berkshire Hathaway is not glamorous, but it is rare: a $1.08 trillion holding company that still earns strong operating cash flows, holds a conservative balance sheet, and now has management continuity under Gregory Abel. That combination matters in markets that are both exuberant and fragile. For investors who favor durable cash generation and disciplined capital allocation, Berkshire offers a trade with asymmetric upside and a defined downside.

My actionable thesis: buy Berkshire A shares around current levels and target the 52-week high. The trade leans on three pillars - steady free cash flow, low leverage, and predictable capital allocation (buybacks and selective acquisitions under the new leadership). Valuation is reasonable for a conglomerate with a 11%+ ROE and substantial operating franchises.

Business overview - why the market should care

Berkshire Hathaway is a diversified holding company operating across Insurance (including GEICO and reinsurance), Burlington Northern Santa Fe railroad (BNSF), Berkshire Hathaway Energy, manufacturing, distribution (McLane), retail, and services. The breadth of cash-generating franchises provides ballast in downturns and optionality in recoveries: industrial earnings, utility regulated returns, insurance float, and sizeable buyback capacity when management chooses.

Key financial characteristics that matter to investors:

  • Berkshire trades with a market capitalization near $1.08 trillion.
  • Price-to-earnings sits in the low-teens (reported around 12.6-12.8), while price-to-book is approximately 1.45, a modest premium to book for a diversified operator.
  • Free cash flow remains meaningful at roughly $24.2 billion annually, supporting buybacks, opportunistic deals and organic reinvestment.
  • Balance sheet conservatism - debt-to-equity about 0.17 and elevated liquidity/coverage metrics - underpins the company’s ability to absorb shocks and act when others sell.

Supporting numbers

The headline math is straightforward and supports a buy-when-it-looks-ordinary case. Berkshire’s enterprise value is roughly $1.17 trillion with an EV/EBITDA near 25.7. Return on equity is healthy at ~11.47% and return on assets around 6.79%—solid for a conglomerate where capital is spread across regulated utilities, trucking, rail and insurance float. Earnings-per-share on the A-share basis is large in nominal terms, reflecting the huge per-share denomination, and price action reflects concentrated, measured moves rather than speculative momentum.

Metric Value
Current price (approx) $759,702.24
Market cap $1.08 trillion
Price / Earnings ~12.6 - 12.8x
Price / Book ~1.45x
Free cash flow (annual) $24.22 billion
Enterprise value $1.17 trillion
EV / EBITDA ~25.7x
Debt / Equity ~0.17
52-week range $698,000 - $806,102.81

Valuation framing

Berkshire is not a high-growth multiple name; it's a value compounder. Trading around 12-13x earnings and ~1.45x book in an environment where high-growth names trade at far higher multiples is comforting. The EV/EBITDA near 25.7 looks elevated on a pure multiple basis, but that metric understates the value of insurance float and long-lived regulated utility earnings. Free cash flow of $24.2 billion gives management optionality: fund operations, buybacks, or pursue larger acquisitions if valuations reset lower.

Relative to its own history, the current multiple is in line with a conservative preference for capital preservation and measured returns, not headline-grabbing growth. The 52-week high at $806,102 provides a practical target that aligns with how the market has recently valued the company at peak sentiment.

Catalysts (why prices could move up)

  • Visible capital deployment under Greg Abel - continued opportunistic buys and disciplined buybacks signal efficient use of free cash flow (news showed recent incremental stake builds in select names on 09/25/2026).
  • Insurance underwriting profitability - an improvement in underwriting margins or favorable reserve development would boost earnings and cash flow.
  • Rail and industrial cyclicals - any re-acceleration in BNSF volumes or manufacturing end markets would lift operating income.
  • Market rotation to value - if sentiment shifts from high-growth AI names toward cash-generative, diversified businesses, Berkshire could re-rate modestly toward historical peers.
  • Buyback cadence - explicit and meaningful share repurchases reduce outstanding shares and can lift per-share metrics if done at attractive prices.

Trade plan (actionable)

Direction: long.

Entry: execute near $759,702.235 (current price reference). Stop loss: $698,000.00. Target: $806,102.81 (the recent 52-week high). Risk level: medium. Time horizon: long term (180 trading days) - I expect this trade to play out over multiple quarters because catalysts like buyback programs, insurance cycle improvements, or industrial recoveries take time to show through in consolidated results and in market sentiment.

Rationale: entry is close to the current trading level, stop beneath the 52-week low gives defined downside (technical pivot and psychological support), and target at the 52-week high is a realistic first take-profit where multiples and sentiment aligned previously. This is not a short-term scalp - Berkshire tends to move with fundamentals and capital allocation announcements, so give the position time to compound.

Risks and counterarguments

There are several credible reasons this trade might underperform the plan; here are the main risks and a balanced counterargument.

  • Macro shock/credit stress. A severe economic slowdown or credit event could depress earnings across BNSF, manufacturing and retail, and increase insurance losses or reserve volatility. Even with low leverage, operating income could compress. That is why the stop is set below $698,000 - to limit capital exposure if the market re-prices conglomerates aggressively.
  • Capital allocation missteps. Under new stewardship, a large acquisition at an inopportune price or excessive buybacks funded by overpaying could erode value. Berkshire’s historic strength is discipline; any departure would be a material negative.
  • Insurance losses or reserve surprises. Catastrophic losses or adverse reserve development in the reinsurance book can swing reported earnings and cash flow, pressuring the shares despite good long-term prospects.
  • Valuation compression from market rotation. If markets continue to favor high-growth AI and technology with little appetite for slow-growing conglomerates, Berkshire’s multiple could compress below current levels, dragging the stock toward the stop.
  • Counterargument - structural underperformance vs growth indices. One can reasonably argue that Berkshire’s slow-growth profile and massive size mean it will lag high-growth indices over medium horizons. For investors chasing alpha from AI-related rally, Berkshire is not the place. That argument has weight: if equities re-rate on growth expectations and Berkshire remains a value play, it may underperform broadly even while delivering solid absolute returns. This trade accepts that relative underperformance risk in exchange for lower volatility and balance sheet resilience.

What would change my view

I would become materially less constructive if any of the following occurred: management materially loosened capital allocation discipline (meaning repeat large, expensive acquisitions or reckless buybacks), debt levels rose meaningfully and unsustainably, or insurance underwriting deteriorated (sustained reserve strengthening beyond actuarial expectations). Conversely, I would raise the target and tighten the stop if management announces a sustained, transparent buyback program or a large sale of non-core assets at attractive prices that meaningfully increases per-share intrinsic value.

Conclusion

Berkshire is an idiosyncratic mix of regulated utility cash, industrial cyclicality, and insurance float. At roughly $759,700 per A-share, the company trades at comfortable multiples given its free cash flow generation, conservative balance sheet and new management continuity. This trade is a practical, conviction-weighted long: entry near the market, a defined stop under the 52-week low, and a realistic target at last year’s high. The plan plays the company’s strengths - cash flow and capital allocation - while acknowledging the macro and valuation risks that could test the position along the way.

Trade idea summary: Long BRK.A at $759,702.235; stop $698,000.00; target $806,102.81; horizon long term (180 trading days); risk level medium.

Watch upcoming quarterly results and capital allocation commentary closely. Those will determine whether Berkshire can quietly compound value the way it has historically - and whether this trade should be scaled up, trimmed, or closed.

Risks

  • Macro shock or credit event that materially reduces volumes at BNSF and industrial units.
  • Insurance underwriting losses or adverse reserve developments that depress earnings and cash flow.
  • Capital allocation missteps by new management resulting in overpaying for acquisitions or poorly timed buybacks.
  • Market rotation into high-growth names causing valuation multiple compression for value/conglomerate stocks.

More from Trade Ideas

Credo’s 1.6T Push: A Tactical Long on AI Connectivity Momentum Sep 25, 2026 Atlassian: Momentum Looks Real, But the Price Already Reflects It Sep 25, 2026 Why I'm Buying Uber Again After Selling in March - Double Upgrade to Long-Term Buy Sep 25, 2026 Tencent's Dream: AI Meets Ubiquitous Distribution - A Mid-term Long Trade Sep 25, 2026 Why AstraZeneca Still Looks Underrated Despite Strong EPS Momentum Sep 25, 2026